Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

87.98
-0.4600-0.52%
Volume:30.70K
Turnover:2.70M
Market Cap:4.29B
PE:-20.35
High:88.51
Open:87.61
Low:87.01
Close:88.44
52wk High:151.02
52wk Low:44.42
Shares:48.77M
Float Shares:29.72M
Volume Ratio:0.42
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-335.69
PE(LYR):-23.21

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Celcuity to Report Q2 Results, Host Webcast Call

Reuters
·
Aug 06

Celcuity announces NCCN recommendation for Revtorpyk combination

TIPRANKS
·
Jul 30

Celcuity Says NCCN Guidelines Add Newly FDA-approved Revtorpyk for Advanced Hr+/her2- Breast Cancer

Reuters
·
Jul 30

Celcuity - FDA Approves Revtorpyk for Hr+/Her2- Advanced Breast Cancer Without Pik3CA Mutation on July 14, 2026

THOMSON REUTERS
·
Jul 30

Newly FDA-Approved Revtorpyk™ (Gedatolisib) Included in the National Comprehensive Cancer Network® (Nccn®) Clinical Practice Guidelines for Hr+/Her2- Locally Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Jul 30

Celcuity - Revtorpyk Expected to be Commercially Available in U.S. in Late Q3 2026

THOMSON REUTERS
·
Jul 30

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

MT Newswires Live
·
Jul 28

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Celcuity Inc : Leerink Partners Raises Target Price to $148 from $147

THOMSON REUTERS
·
Jul 27

3 Stocks With Healthy Growth Potential Investors Should Watch

Simply Wall St.
·
Jul 19

Celcuity (CELC) Receives a Buy from Leerink Partners

TIPRANKS
·
Jul 17

3 High Growth Commodity Stocks With Healthy Balance Sheets

Simply Wall St.
·
Jul 17

Baker Bros. Advisors Reports Celcuity Share Disposal Worth $317.5 Million

Reuters
·
Jul 17

Celcuity Shares Fall as Launch Delay Eclipses US Approval for Breast Cancer Drug

Reuters
·
Jul 15

Analysts’ Top Healthcare Picks: Denali Therapeutics (DNLI), Celcuity (CELC)

TIPRANKS
·
Jul 15

Celcuity falls -12.6%

TIPRANKS
·
Jul 15

Movement Alert|Celcuity Inc Falls 22.15% in Regular Trading, FDA Approval of Core Drug Triggers Classic Sell-the-News Selloff

Market Focus
·
Jul 15

Celcuity Shares Fall 22% as Delayed Launch of New Breast Cancer Drug Overshadows First U.S. Approval

THOMSON REUTERS
·
Jul 15

Movement Alert|Celcuity Inc Falls 5.59% in Pre-Market Trading, FDA Approves Core Drug Triggering Sell-the-News Reaction

Market Focus
·
Jul 15